Page 5 - Les meilleurs doctors traitant la maladie suivante : Cancer de l'estomac - TOP -145 des médecins

Spécialisée en virothérapie – une approche immunologique de pointe pour le cancer de l'estomac – le Dr Jaunalksne apporte plus de 30 ans d'expertise à la Clinique Pallas.

• Diriger le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômer de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les traitements immunologiques innovants

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Le Dr Alexander Beny est le directeur du service des tumeurs gastro-intestinales au centre médical Rambam, où il supervise une clinique spécialisée dans le cancer de l'estomac.

• Il possède une formation avancée de l'ESTRO sur les techniques modernes de curiethérapie.
• Il a effectué son internat complet en oncologie médicale et radiothérapie à Rambam.
• Son travail se concentre sur la clinique d'oncologie gastro-intestinale.
• Il est certifié par la Communauté européenne et les conseils médicaux israéliens.

Chef adjoint du département d'oncologie du centre médical Rambam – un rôle de premier plan dans le traitement du cancer de l'estomac.

• Se spécialiser en oncologie gastro-intestinale
• Travailler dans l'un des meilleurs centres médicaux d'Israël
• Se concentrer sur des approches de traitement avancées

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Spécialisé dans le cancer gastrique et la chirurgie oncologique, proposant des traitements ciblés aux hôpitaux Büyük Anadolu.

• Être expert en chirurgies du pancréas et des voies biliaires
• Pratiquer des chirurgies bariatriques et métaboliques
• Être qualifié pour les interventions sur le cancer du colon et de la thyroïde

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Kariv est spécialisé en chirurgie laparoscopique et colorectale, apportant précision et expertise au traitement du cancer de l'estomac.

• Se concentrer sur les techniques mini-invasives pour de meilleurs résultats pour les patients
• Se spécialiser en chirurgie colorectale, assurant des soins complets
• Pratiquer au centre médical Assuta, reconnu pour ses traitements oncologiques de pointe

Le Dr Leng Yin est spécialisé dans le traitement des cancers du foie, de la vésicule biliaire, de l'estomac, du pancréas et des intestins à l'hôpital Fuda Cancer.

• Oncologue expérimenté ayant travaillé aux hôpitaux Bumrungrad International et Royal Siriraj
• Membre de l'Association chinoise de lutte contre le cancer
• Expertise dans le diagnostic et le traitement des cancers gastro-intestinaux

Le Dr Gutman se spécialise dans la chirurgie du cancer de l'estomac au centre médical Assuta.

• Oncochirurgien expérimenté spécialisé dans les cancers gastro-intestinaux
• Travailler au centre médical Assuta – un établissement d'oncologie de premier plan
• Élaborer des plans de traitement personnalisés pour chaque patient

La Dre Zalmanova est spécialisée en radiothérapie pour le cancer de l'estomac au centre médical Assuta.

• Radiothérapeute spécialisée dans le traitement du cancer de l'estomac
• Travail au centre médical Assuta, un établissement de santé de premier plan
• Élaboration de plans de traitement personnalisés pour chaque patient

Le Dr Joseba Rebollo Liceaga apporte plus de 30 ans d'expérience dévouée en oncologie médicale, se spécialisant dans le cancer de l'estomac à Quirónsalud Alicante.

• Ancien chef du service d'oncologie de la Clínica San Miguel de Navarra et de l'Hospital General de Villalba
• Résidence et formation spécialisée à la Clínica Universidad de Navarra
• Rédiger des recherches sur l'électrochimiothérapie et les traitements multidisciplinaires du cancer
• Suivre plusieurs cours de perfectionnement en oncologie multidisciplinaire

Chef du service d'onco-radiothérapie au Samsung Medical Center, le Pr Lim est spécialisé dans le traitement du cancer de l'estomac, en mettant l'accent sur la radiothérapie de précision.

• Formation à l'hôpital universitaire national de Séoul et au Samsung Medical Center
• Spécialisation dans les tumeurs de l'estomac, pancréatobiliaires et du SNC
• Direction d'un département d'onco-radiothérapie de premier plan

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Ezgi Sevic est spécialisée dans la nutrition des patients atteints de cancer et a mené des recherches sur les maladies chroniques et l'obésité lors de ses études à l'université Hacettepe.

• Obtenir son diplôme avec mention de l'université Hacettepe
• Mener des études sur « La relation entre la résistance à l'insuline et l'obésité »
• Se former à la nutrition post-chirurgie métabolique et bariatrique
• Maîtriser l'anglais avancé